Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-Week results of the VICTOR-El phase 2 trial

Jamal Suleiman, Barry S. Zingman, Ricardo Sobhie Diaz, Jose Valdez Ramalho Madruga, Edwin Dejesus, Jihad Slim, Carmen Mak, Erin Lee, Michael C. McCarthy, M. Dunkle, Sharon Walmsley

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint Dive into the research topics of 'Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-Week results of the VICTOR-El phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences